Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection
Jay W. Hooper(United States Army Medical Research Institute of Infectious Diseases), Trevor Wellington(Walter Reed Army Institute of Research), Jeffrey Livezey(Uniformed Services University of the Health Sciences), Jason I. Koontz(United States Army Medical Research and Development Command), Jack Hutter, Steven A. Kwilas(United States Army Medical Research Institute of Infectious Diseases), Carmen Ledesma‐Feliciano(University of Colorado Anschutz Medical Campus), Melinda Hamer, Kristopher Paolino(Walter Reed National Military Medical Center), Sarah L. Norris(United States Army Medical Research Institute of Infectious Diseases), Michael Koren(Jacksonville University), Paul B. Keiser(Walter Reed Army Institute of Research), James E. Moon(Walter Reed Army Institute of Research), Patrick Twomey(Walter Reed Army Institute of Research), Matthew Josleyn(United States Army Medical Research Institute of Infectious Diseases), Ugo Nwaeze(United States Army Medical Research and Development Command), Nathalie Landry(Medicago (Canada))
Cited by 11
Related Papers
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
|Gastroenterology|2021|177
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
|Annals of Internal Medicine|2020|93